<DOC>
	<DOCNO>NCT00529711</DOCNO>
	<brief_summary>Previous clinical trial 11.2 % Hypertonic Ringer 's Lactate post-operative CABG subject show increase several cardiac performance parameter , less volume resuscitation fluid require reach circulation volume , compare Sodium Chloride.It also cause hyperchloremic acidosis , value treat shock patient . The primary objective prospective , randomize , open-label trial evaluate clinical efficacy hypertonic lactate comparison Ringer 's lactate maintain hemodynamic stability intra- post-CABG subject relation hemodynamic status body fluid balance , well assess safety term lab parameter occurrence adverse events.The secondary objective evaluate comparative clinical efficacy two fluid relation reduction concomitant drug utilization , duration ventilator usage , length stay ICU well total duration hospitalization neurocognitive status upto period 1 year post-CABG .</brief_summary>
	<brief_title>The Efficacy Hypertonic Lactate Solution CABG ( Coronary Artery Bypass Grafting ) Patients</brief_title>
	<detailed_description>Details provide summary .</detailed_description>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male female 45 80 year CABG patient pump procedure Ejection fraction &lt; 50 % Given inform consent Combined operation Severe arrhythmia ( VT , AF rapid response , heart block ) severe hemodynamic imbalance Severe bleed and/or reoperation Hypernatremia &gt; 155 mMol/L Severe liver failure ( SGOT , SGPT 2x normal ) Severe renal failure ( Creatinine &gt; 2 mg. % ) Major disease ( eg . cancer )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>coronary</keyword>
	<keyword>artery</keyword>
	<keyword>bypass</keyword>
	<keyword>graft</keyword>
	<keyword>IV</keyword>
	<keyword>cardiac output</keyword>
</DOC>